Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders

NCT06672705 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
EBV-Related Post-Transplant Lymphoproliferative Disorder
Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder
Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder
Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder
Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder

Interventions

PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Epcoritamab
PROCEDURE: Positron Emission Tomography

Sponsor

Timothy Voorhees

Collaborators

[object Object]
[object Object]